Clinical Trials Logo

Cystocele clinical trials

View clinical trials related to Cystocele.

Filter by:

NCT ID: NCT04184752 Completed - Voiding Disorders Clinical Trials

Prevalence of Detrusor Underactivity and Bladder Outlet Obstruction in Female Without Cystocele

Start date: April 1, 1996
Phase:
Study type: Observational

Women with symptoms of voiding dysfunction may be associated with detrusor underactivity (DU) or bladder outlet obstruction (BOO). The treatment strategies are different between DU and BOO. In general, urodynamic/videourodynamic studies are important for differential diagnosis. However, urodynamic/videourodynamic studies are invasive. The investigators are interested in whether there were specific symptoms or measurements that can be used for initial differential diagnosis between DU and BOO. Thus, the aim of this study was to elucidate the prevalence of DU and BOO in each age group and elucidate the clinical and urodynamic differences between the DU, BOO and non-DU/BOO groups.

NCT ID: NCT04184128 Completed - Cystocele Clinical Trials

Detrusor Underactivity and Bladder Outlet Obstruction in Women With Cystocele

Start date: November 1, 2010
Phase:
Study type: Observational

Women with cystocele may be associated with detrusor underactivity (DU) or bladder outlet obstruction (BOO). However, the impact of cystocele repair on the rates of DU and BOO remained obscure. Thus, the aim of this study was to elucidate the prevalence of DU and BOO in each age group and elucidate the impact of cystocele repair on the rates of DU and BOO.

NCT ID: NCT04175782 Completed - Clinical trials for Urinary Incontinence

Enhanced Recovery Protocol in Urogynecologic Surgery

Start date: July 20, 2019
Phase: N/A
Study type: Interventional

Enhanced recovery after surgery (ERAS) has been shown to improve postoperative outcomes in a variety of surgical conditions. However, data regarding its role in urogynecologic surgery is limited. This study aimed to investigate the role of the ERAS protocol on postoperative outcomes in patients undergoing urogynecologic surgery.

NCT ID: NCT04038099 Completed - Clinical trials for Urinary Incontinence

Lessons on Urethral Lidocaine in Urodynamics

LULU
Start date: August 14, 2019
Phase: Phase 4
Study type: Interventional

This trial will assess whether use of intraurethral 2% lidocaine jelly meaningfully impacts sensation during filling (i.e., a change of more than 25% of first sensation, first desire to void, strong desire to void, or maximum cystometric capacity) and determine whether the use of intraurethral 2% lidocaine jelly meaningfully impacts pain/discomfort, filling metrics, and voiding metrics.

NCT ID: NCT04009694 Recruiting - Clinical trials for Pelvic Organ Prolapse

Does a High BMI Affect Supervised Pelvic Floor Muscle Training for Improving Symptoms in Women With Various Stages of Pelvic Organ Prolapse?

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The trial design is a quasi-experimental cohort trial that includes women referred for pelvic organ prolapse specific physiotherapy. Candidates will be selected via a convenience sampling method from four physiotherapy outpatient departments at a NHS trust within Greater Manchester. The data collection occurred in January-June 2019 and ethical approval was granted by School Research Ethics, University of Salford. Treatment aims to ensure there is respect for their autonomy, treatment is fair (Justice), no harm is done to the participant (nonmaleficence) and treatment benefits the participants (beneficence). Participants are required to complete a consent form prior to their initial session. To ensure methodological quality, the STROBE guidelines will be followed to make certain all apt information required is reported to allow for replication of the intervention. The trial aims to include (n=60) women with a diagnosed pelvic organ prolapse. They are required to complete 16 weeks of supervised pelvic floor exercises with a specialist physiotherapist as documented within the most recent NICE guidelines. The outcome measures used will be the Pelvic Organ Prolapse symptom score (POPSS) and this will be documented before and after the 16 week period. Along side the POPSS, the patients body mass index and severity of pelvic organ prolapse will also be recorded and the results of this will be correlated post trial using the relevant data analysis testing methods.

NCT ID: NCT03962075 Completed - Prolapse, Vaginal Clinical Trials

Short-term Outcomes of Laparoscopic Repair of Paravaginal Defects

Start date: August 1, 2016
Phase: N/A
Study type: Interventional

this study designed To evaluate the efficacy and outcomes of laparoscopic approach for repair of paravaginal defects associated with anterior vaginal wall prolapse.

NCT ID: NCT03714607 Active, not recruiting - Cystocele Clinical Trials

Laser Therapy in Managing Vaginal Prolapse

Start date: November 30, 2018
Phase: N/A
Study type: Interventional

Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage >1. Assessment tools will include prolapse stage quantification system (POP-Q) and validated condition related questionnaires.

NCT ID: NCT03613350 Completed - Clinical trials for Lower Urinary Tract Symptom in Severe Cystocele Women

Prevalence Rates of USI, BO, DO and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele

Start date: November 1, 2011
Phase:
Study type: Observational

Prevalence rates of urodynamic stress incontinence (USI), bladder oversensitivity (BO) /detrusor overactivity (DO) or both and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation. Thus, the aim of this study was to elucidate the above findings and between-group associations.

NCT ID: NCT03613324 Completed - Clinical trials for Bladder Outlet Obstruction and Detrusor Underactivity in Women With Severe Cystocele

BOO and DU and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele

Start date: January 1, 2011
Phase:
Study type: Observational

Prevalence rates of bladder outlet obstruction (BOO) and detrusor underactivity (DU) and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation. Thus, the aim of this study was to elucidate the above findings and between-group associations.

NCT ID: NCT03613311 Completed - Clinical trials for Urodynamic Stress Incontinence in Severe Cystocele Women

Evident, Occult and no Demonstrated USI and UDS Findings in Women With ≥Stage II Cystocele

Start date: November 1, 2011
Phase:
Study type: Observational

Prevalence rates of urodynamic urinary incontinence (USI) subtypes and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation, especially for occult USI. Misdiagnosis of occult USI before cystocele repair might lead to occurrence of de novo stress urinary incontinence after cystocele repair. Thus, the aim of this study was to elucidate the above findings and between-group associations.